Hyloris Pharmaceuticals SA

ENXTBR:HYL Stock Report

Market Cap: €169.7m

Hyloris Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Stijn Van Rompay

Chief executive officer

€212.8k

Total compensation

CEO salary percentage89.7%
CEO tenure4.8yrs
CEO ownership36.7%
Management average tenureno data
Board average tenure4.8yrs

Recent management updates

Recent updates

Here's Why We're Not Too Worried About Hyloris Pharmaceuticals' (EBR:HYL) Cash Burn Situation

Aug 04
Here's Why We're Not Too Worried About Hyloris Pharmaceuticals' (EBR:HYL) Cash Burn Situation

Hyloris Pharmaceuticals (EBR:HYL) Is In A Strong Position To Grow Its Business

Dec 28
Hyloris Pharmaceuticals (EBR:HYL) Is In A Strong Position To Grow Its Business

Do Institutions Own Hyloris Pharmaceuticals SA (EBR:HYL) Shares?

Mar 08
Do Institutions Own Hyloris Pharmaceuticals SA (EBR:HYL) Shares?

CEO Compensation Analysis

How has Stijn Van Rompay's remuneration changed compared to Hyloris Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023€213k€191k

-€15m

Compensation vs Market: Stijn's total compensation ($USD232.06K) is below average for companies of similar size in the Belgian market ($USD707.51K).

Compensation vs Earnings: Insufficient data to compare Stijn's compensation with company performance.


CEO

Stijn Van Rompay (48 yo)

4.8yrs

Tenure

€212,820

Compensation

Mr. Stijn Van Rompay is a Co-Founder and Chief Executive Officer of Hyloris Pharmaceuticals SA and serves as its Director since 2020. He was the Chief Executive Officer of Alter Pharma, a high-growth pharm...


Board Members

NamePositionTenureCompensationOwnership
Stijn Van Rompay
Co-Founder4.8yrs€212.82k36.67%
€ 62.2m
Thomas Jacobsen
Co-Founder4.8yrsno data13.78%
€ 23.4m
James Gale
Independent Director4.8yrs€17.50kno data
Stefan Yee
Chairman of the Board4.8yrs€22.50kno data
Leon Van Rompay
Non-Executive Director4.8yrs€12.50kno data
Chris Buyse
Independent Director3.3yrs€17.50kno data
Carolyn Myers
Non-Executive Director4.8yrs€17.50kno data
Marc Foidart
Independent Director4.8yrs€22.50kno data

4.8yrs

Average Tenure

61yo

Average Age

Experienced Board: HYL's board of directors are considered experienced (4.8 years average tenure).